Submit your email to push it up the queue
DiaSorin Inc., a prominent player in the diagnostics industry, is headquartered in the United States and operates extensively across Europe, Asia, and Latin America. Founded in 1968, the company has established itself as a leader in the development of innovative diagnostic solutions, particularly in the fields of infectious diseases, oncology, and endocrinology. With a diverse portfolio of products, DiaSorin is renowned for its unique immunodiagnostic assays and molecular diagnostics, which leverage advanced technology to deliver accurate and timely results. The company’s commitment to quality and innovation has positioned it favourably in the global market, earning recognition for its contributions to healthcare. Notable achievements include a robust pipeline of cutting-edge tests and a strong presence in both hospital and laboratory settings, making DiaSorin Inc. a trusted name in the diagnostics sector.
How does DiaSorin Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
DiaSorin Inc.'s score of 36 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
DiaSorin Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of DiaSorin S.p.A., which may influence its climate commitments and emissions reporting. As of now, DiaSorin Inc. has not established any documented reduction targets or initiatives related to carbon emissions. The absence of specific emissions data and reduction commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the lack of direct emissions data, it is important to note that DiaSorin Inc.'s climate commitments may be informed by the broader initiatives of its parent company, DiaSorin S.p.A. However, no specific targets or initiatives have been cascaded from the parent organisation that are publicly available. In summary, DiaSorin Inc. is currently without specific emissions data or reduction targets, reflecting a potential area for future development in their climate strategy.
Access structured emissions data, company-specific emission factors, and source documents
2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Scope 1 | 3,223,720 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 2 | 8,426,130 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
DiaSorin Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.